paclitaxel has been researched along with Brachial Paresis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaén, P; Muñoz-Zato, E; Pérez, B; Truchuelo, M; Vano-Galvan, S | 1 |
| Brem, H; Caplan, J; Fowers, KD; Hdeib, A; Jallo, G; Legnani, FG; Pradilla, G; Tyler, BM | 1 |
| Bagley, CA; Bookland, MJ; Gokaslan, ZL; Ozmen, T; Pindrik, JA; Witham, TF | 1 |
3 other study(ies) available for paclitaxel and Brachial Paresis
| Article | Year |
|---|---|
Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Capecitabine; Carboplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Fatal Outcome; Female; Fluorouracil; Hand; Humans; Lapatinib; Middle Aged; Onycholysis; Paclitaxel; Paresis; Peripheral Nervous System Diseases; Quinazolines; Taxoids; Trastuzumab; Vinblastine; Vinorelbine | 2009 |
Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Drug Delivery Systems; Female; Gels; Gliosarcoma; Paclitaxel; Paresis; Rats; Rats, Inbred F344; Spinal Cord Neoplasms | 2012 |
Local delivery of oncogel delays paresis in rat metastatic spinal tumor model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Injections, Intralesional; Neoplasm Transplantation; Paclitaxel; Paresis; Polymers; Rats; Rats, Inbred F344; Spinal Neoplasms; Survival Analysis | 2007 |